chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Hot flush, Hyposmia, Myalgia
Clinical narrative: Not able to taste Gatorade; Reduced smell; Severe body aches; Chills; Nausea; Hot flashes without fever; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes without fever), AGEUSIA (Not able to taste Gatorade), HYPOSMIA (Reduced smell), MYALGIA (Severe body aches) and CHILLS (Chills) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced HOT FLUSH (Hot flashes without fever), MYALGIA (Severe body aches), CHILLS (Chills) and NAUSEA (Nausea). On 30-Apr-2021, the patient experienced AGEUSIA (Not able to taste Gatorade) and HYPOSMIA (Reduced smell). At the time of the report, HOT FLUSH (Hot flashes without fever), AGEUSIA (Not able to taste Gatorade), HYPOSMIA (Reduced smell), MYALGIA (Severe body aches), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            Concomitant medication were not reported.  Treatment medications were not reported
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Not able to taste Gatorade; Reduced smell; Severe body aches; Chills; Nausea; Hot flashes without fever; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (Hot flashes without fever), AGEUSIA (Not able to taste Gatorade), HYPOSMIA (Reduced smell), MYALGIA (Severe body aches) and CHILLS (Chills) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced HOT FLUSH (Hot flashes without fever), MYALGIA (Severe body aches), CHILLS (Chills) and NAUSEA (Nausea). On 30-Apr-2021, the patient experienced AGEUSIA (Not able to taste Gatorade) and HYPOSMIA (Reduced smell). At the time of the report, HOT FLUSH (Hot flashes without fever), AGEUSIA (Not able to taste Gatorade), HYPOSMIA (Reduced smell), MYALGIA (Severe body aches), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            Concomitant medication were not reported.  Treatment medications were not reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Headache, Musculoskeletal stiffness, Vaccination site pain
Clinical narrative: Exposed to COVID19 after 1st dose of Moderna COVID19 vaccine; tender at injection site; headache; stiff neck on left side (underneath base of skull to neck and shoulders); This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck on left side (underneath base of skull to neck and shoulders)), EXPOSURE TO SARS-COV-2 (Exposed to COVID19 after 1st dose of Moderna COVID19 vaccine), VACCINATION SITE PAIN (tender at injection site) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031BUA) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck on left side (underneath base of skull to neck and shoulders)), VACCINATION SITE PAIN (tender at injection site) and HEADACHE (headache). On 26-Apr-2021, the patient experienced EXPOSURE TO SARS-COV-2 (Exposed to COVID19 after 1st dose of Moderna COVID19 vaccine). On 28-Apr-2021, MUSCULOSKELETAL STIFFNESS (stiff neck on left side (underneath base of skull to neck and shoulders)), VACCINATION SITE PAIN (tender at injection site) and HEADACHE (headache) outcome was unknown. At the time of the report, EXPOSURE TO SARS-COV-2 (Exposed to COVID19 after 1st dose of Moderna COVID19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment was unknown.  Consent for follow-up with health care provider.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Myalgia, Nausea, Pain in extremity
Clinical narrative: Pain in arms; Felt totally wiped out; Fever; Chills; Muscle pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (Felt totally wiped out), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle pain) in a 58-year-old female patient who received mRNA-1273 (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Mar-2021, the patient received second dose of mRNA-1273 (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (Felt totally wiped out), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (Felt totally wiped out), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and NAUSEA (Nausea) outcome was unknown.            No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Pain in arms; Felt totally wiped out; Fever; Chills; Muscle pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (Felt totally wiped out), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Muscle pain) in a 58-year-old female patient who received mRNA-1273 (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Mar-2021, the patient received second dose of mRNA-1273 (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (Felt totally wiped out), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (Felt totally wiped out), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle pain) and NAUSEA (Nausea) outcome was unknown.            No treatment information was provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lip swelling
Clinical narrative: flu like symptoms; swollen lips; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and LIP SWELLING (swollen lips) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. NA) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and LIP SWELLING (swollen lips). On 28-Apr-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown. On 29-Apr-2021, LIP SWELLING (swollen lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication provided. treatment medication include ibuprofen, benadryl
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Stiff neck; Swollen right arm lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck) and LYMPHADENOPATHY (Swollen right arm lymph nodes) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck) and LYMPHADENOPATHY (Swollen right arm lymph nodes). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck) and LYMPHADENOPATHY (Swollen right arm lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication and treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Blood test abnormal, Immune system disorder, Protein total abnormal
Clinical narrative: Something is not right with her immune system; Arthritis went off the charts; Abnormal findings( high protein); Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNE SYSTEM DISORDER (Something is not right with her immune system), ARTHRITIS (Arthritis went off the charts), PROTEIN TOTAL ABNORMAL (Abnormal findings( high protein)) and ARTHRALGIA (Shoulder pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced IMMUNE SYSTEM DISORDER (Something is not right with her immune system), ARTHRITIS (Arthritis went off the charts), PROTEIN TOTAL ABNORMAL (Abnormal findings( high protein)) and ARTHRALGIA (Shoulder pain). At the time of the report, IMMUNE SYSTEM DISORDER (Something is not right with her immune system), ARTHRITIS (Arthritis went off the charts), PROTEIN TOTAL ABNORMAL (Abnormal findings( high protein)) and ARTHRALGIA (Shoulder pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test abnormal: high (High) High abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that she had taken her anti inflammatory medications before receiving the 1st dose and stated that the Adverse events may be due to that.The patient stated that for the 2nd dose she took the anti inflammatory medications after receiving 2nd dose.   This case was linked to MOD-2021-100828 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: I was reading online and it is called Covid arm; Around 4 inches across and 3 inches wide; Very itchy; Red area around the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (I was reading online and it is called Covid arm), RASH (Around 4 inches across and 3 inches wide), VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE ERYTHEMA (Red area around the injection site) and PYREXIA (Fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE REACTION (I was reading online and it is called Covid arm), RASH (Around 4 inches across and 3 inches wide), VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE ERYTHEMA (Red area around the injection site) and PYREXIA (Fever). At the time of the report, VACCINATION SITE REACTION (I was reading online and it is called Covid arm), RASH (Around 4 inches across and 3 inches wide), VACCINATION SITE PRURITUS (Very itchy), VACCINATION SITE ERYTHEMA (Red area around the injection site) and PYREXIA (Fever) outcome was unknown.            No concomitant medication provided.  No treatment information mentioned.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Myalgia, Vaccination site erythema, Vaccination site pain
Clinical narrative: rash 2 inches away from the site of injection; red bump around the site of injection; warm to touch; red bump around the site of injection; muscle aches; pain at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red bump around the site of injection), MYALGIA (muscle aches), VACCINATION SITE PAIN (pain at the site of injection) and VACCINATION SITE RASH (rash 2 inches away from the site of injection) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and CITALOPRAM for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced INJECTION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red bump around the site of injection), MYALGIA (muscle aches), VACCINATION SITE PAIN (pain at the site of injection) and INJECTION SITE SWELLING (red bump around the site of injection). On 01-May-2021, the patient experienced VACCINATION SITE RASH (rash 2 inches away from the site of injection). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red bump around the site of injection), MYALGIA (muscle aches), VACCINATION SITE PAIN (pain at the site of injection), VACCINATION SITE RASH (rash 2 inches away from the site of injection) and INJECTION SITE SWELLING (red bump around the site of injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment Medication includes: Ibuprofen and Tylenol. Action taken with mRNA-1273 in response to the event was not applicable. She received the second dose (Lot: 048B21A, expiration:unknown) on 29APR2021 at 4 PM on her right upper arm. On Friday 30APR2021, she had a red bump around the site of injection that was warm to touch. She also had pain at the site of injection and muscles aches. She took Ibuprofen and Tylenol. On 01MAY2021, she noticed another rash 2 inches away from the site of injection. Patient is currently taking citalopram 40 mg and prenatal vitamin.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash 2 inches away from the site of injection; red bump around the site of injection; warm to touch; red bump around the site of injection; muscle aches; pain at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red bump around the site of injection), MYALGIA (muscle aches), VACCINATION SITE PAIN (pain at the site of injection) and VACCINATION SITE RASH (rash 2 inches away from the site of injection) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and CITALOPRAM for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced INJECTION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red bump around the site of injection), MYALGIA (muscle aches), VACCINATION SITE PAIN (pain at the site of injection) and INJECTION SITE SWELLING (red bump around the site of injection). On 01-May-2021, the patient experienced VACCINATION SITE RASH (rash 2 inches away from the site of injection). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency and PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (warm to touch), VACCINATION SITE ERYTHEMA (red bump around the site of injection), MYALGIA (muscle aches), VACCINATION SITE PAIN (pain at the site of injection), VACCINATION SITE RASH (rash 2 inches away from the site of injection) and INJECTION SITE SWELLING (red bump around the site of injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment Medication includes: Ibuprofen and Tylenol. Action taken with mRNA-1273 in response to the event was not applicable. She received the second dose (Lot: 048B21A, expiration:unknown) on 29APR2021 at 4 PM on her right upper arm. On Friday 30APR2021, she had a red bump around the site of injection that was warm to touch. She also had pain at the site of injection and muscles aches. She took Ibuprofen and Tylenol. On 01MAY2021, she noticed another rash 2 inches away from the site of injection. Patient is currently taking citalopram 40 mg and prenatal vitamin.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Stomach problems; Fever; Soreness around the vaccination site; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach problems), PYREXIA (Fever), VACCINATION SITE PAIN (Soreness around the vaccination site) and NAUSEA (Nausea) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included METOPROLOL, ATORVASTATIN, LOSARTAN POTASSIUM, TRAZODONE and BUPROPION for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach problems), PYREXIA (Fever), VACCINATION SITE PAIN (Soreness around the vaccination site) and NAUSEA (Nausea). At the time of the report, ABDOMINAL DISCOMFORT (Stomach problems), PYREXIA (Fever), VACCINATION SITE PAIN (Soreness around the vaccination site) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.; Sender's Comments:  MOD-2021-100622:Wife's Case
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Influenza like illness, Pyrexia
Clinical narrative: Fever of 101.5 degree Fahrenheit; Headache; Flu like symptoms; Tiredness; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Tiredness), PYREXIA (Fever of 101.5 degree Fahrenheit) and HEADACHE (Headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, HYDROCHLOROTHIAZIDE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Tiredness). On 29-Apr-2021, the patient experienced PYREXIA (Fever of 101.5 degree Fahrenheit) and HEADACHE (Headache). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Tiredness), PYREXIA (Fever of 101.5 degree Fahrenheit) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Apr-2021, Body temperature: 101.5 (Inconclusive) 101.5 degree Fahrenheit.         The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Treatment information included ibuprofen.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown.            Treatment medication not provided. Concomitant medication not provided.   This case was linked to MOD-2021-020592 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Pain in extremity
Clinical narrative: coughing; headaches; sore right arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore right arm), COUGH (coughing) and HEADACHE (headaches) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore right arm). On 29-Apr-2021, the patient experienced COUGH (coughing) and HEADACHE (headaches). The patient was treated with BENZOCAINE at an unspecified dose and frequency and MENTHOL for Cough, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore right arm) had resolved and COUGH (coughing) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and Unknown) for COVID-19 immunisation.     No Medical history was provided by the reporter.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with ACETAMINOPHEN for Headache, Nausea and Dizziness, at a dose of UNK dosage form. At the time of the report, DIZZINESS (Dizziness), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.            The patient took Acetaminophen for as treatment for the events. The patient was feeling little better as of the reporting date. No information of HCP or concomitant medication was provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site inflammation, Myalgia, Pyrexia
Clinical narrative: Inflammation at injection site; body ache; fatigue; fever; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE INFLAMMATION (Inflammation at injection site), MYALGIA (body ache), FATIGUE (fatigue) and PYREXIA (fever) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced INJECTION SITE INFLAMMATION (Inflammation at injection site), MYALGIA (body ache), FATIGUE (fatigue) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INJECTION SITE INFLAMMATION (Inflammation at injection site), MYALGIA (body ache), FATIGUE (fatigue) and PYREXIA (fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No laboratory data was provided. Treatment included paracetamol.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Chills, Pyrexia
Clinical narrative: Bone Pain; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bone Pain), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BONE PAIN (Bone Pain), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, BONE PAIN (Bone Pain), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.6 (High) 100.6 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information for the events was provided.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Ear swelling, Fatigue, Headache, Joint swelling
Clinical narrative: urticaria/hives; both arms heavy and numb; large swollen bump at elbow, smaller bumps surrounding the bump at elbow; burning sensation on left ear/burning on back of neck; left ear is swollen; rash throughout her body; itchy; sleepy/drowsy; Tired; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (sleepy/drowsy), PRURITUS (itchy), URTICARIA (urticaria/hives), LIMB DISCOMFORT (both arms heavy and numb) and JOINT SWELLING (large swollen bump at elbow, smaller bumps surrounding the bump at elbow) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced SOMNOLENCE (sleepy/drowsy), FATIGUE (Tired) and HEADACHE (headache). On 29-Apr-2021, the patient experienced PRURITUS (itchy). On 30-Apr-2021, the patient experienced URTICARIA (urticaria/hives), LIMB DISCOMFORT (both arms heavy and numb), JOINT SWELLING (large swollen bump at elbow, smaller bumps surrounding the bump at elbow) and EAR SWELLING (left ear is swollen). 30-Apr-2021, the patient experienced BURNING SENSATION (burning sensation on left ear/burning on back of neck) and RASH (rash throughout her body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 29-Apr-2021 at an unspecified dose and frequency; HYDROCORTISONE on 29-Apr-2021 at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (CALADRYL [DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) on 30-Apr-2021 at an unspecified dose and frequency and LORATADINE on 30-Apr-2021 at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (sleepy/drowsy), PRURITUS (itchy), URTICARIA (urticaria/hives), LIMB DISCOMFORT (both arms heavy and numb), JOINT SWELLING (large swollen bump at elbow, smaller bumps surrounding the bump at elbow), BURNING SENSATION (burning sensation on left ear/burning on back of neck), EAR SWELLING (left ear is swollen), RASH (rash throughout her body), FATIGUE (Tired) and HEADACHE (headache) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided by reporter.    Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non Significant FU- Obtained correct email id
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pruritus, Rash, Somnolence, Urticaria
Clinical narrative: urticaria/hives; both arms heavy and numb; large swollen bump at elbow, smaller bumps surrounding the bump at elbow; burning sensation on left ear/burning on back of neck; left ear is swollen; rash throughout her body; itchy; sleepy/drowsy; Tired; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (sleepy/drowsy), PRURITUS (itchy), URTICARIA (urticaria/hives), LIMB DISCOMFORT (both arms heavy and numb) and JOINT SWELLING (large swollen bump at elbow, smaller bumps surrounding the bump at elbow) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced SOMNOLENCE (sleepy/drowsy), FATIGUE (Tired) and HEADACHE (headache). On 29-Apr-2021, the patient experienced PRURITUS (itchy). On 30-Apr-2021, the patient experienced URTICARIA (urticaria/hives), LIMB DISCOMFORT (both arms heavy and numb), JOINT SWELLING (large swollen bump at elbow, smaller bumps surrounding the bump at elbow) and EAR SWELLING (left ear is swollen). 30-Apr-2021, the patient experienced BURNING SENSATION (burning sensation on left ear/burning on back of neck) and RASH (rash throughout her body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 29-Apr-2021 at an unspecified dose and frequency; HYDROCORTISONE on 29-Apr-2021 at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (CALADRYL [DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) on 30-Apr-2021 at an unspecified dose and frequency and LORATADINE on 30-Apr-2021 at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (sleepy/drowsy), PRURITUS (itchy), URTICARIA (urticaria/hives), LIMB DISCOMFORT (both arms heavy and numb), JOINT SWELLING (large swollen bump at elbow, smaller bumps surrounding the bump at elbow), BURNING SENSATION (burning sensation on left ear/burning on back of neck), EAR SWELLING (left ear is swollen), RASH (rash throughout her body), FATIGUE (Tired) and HEADACHE (headache) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided by reporter.    Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non Significant FU- Obtained correct email id
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Lymphadenopathy, Pain in extremity, Pyrexia
Clinical narrative: severe pain in arm; Swollen posterior cervical lymph node/ Enlargement of lymph nodes; shaking chills; Fever 103F; Shaking; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (Shaking), PAIN IN EXTREMITY (severe pain in arm), PYREXIA (Fever 103F), LYMPHADENOPATHY (Swollen posterior cervical lymph node/ Enlargement of lymph nodes) and CHILLS (shaking chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and Unknown) for COVID-19 vaccination.     No Medical history was provided by the reporter.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced TREMOR (Shaking), PYREXIA (Fever 103F) and CHILLS (shaking chills). On an unknown date, the patient experienced PAIN IN EXTREMITY (severe pain in arm) and LYMPHADENOPATHY (Swollen posterior cervical lymph node/ Enlargement of lymph nodes). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 26-Apr-2021, TREMOR (Shaking), PYREXIA (Fever 103F) and CHILLS (shaking chills) had resolved. On 14-Jun-2021, LYMPHADENOPATHY (Swollen posterior cervical lymph node/ Enlargement of lymph nodes) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (severe pain in arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: 103 High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was unknown by the reporter.  Patient reported the blood work testing for Sjogren's disease and Lupus. Patient also reported that she had to put off a mammogram due to side effects as fever and shaking chills.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-100836 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: NNI On 06-Jun-2021: NNI On 07-Jun-2021: Patient initials was added On 10-Jun-2021: Event added On 14-Jun-2021: Event and Patient Initials updated.  E2b linked report added. On 27-Jul-2021: Significant FU :  AE Details provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: severe pain in arm; Swollen posterior cervical lymph node/ Enlargement of lymph nodes; shaking chills; Fever 103F; Shaking; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (Shaking), PAIN IN EXTREMITY (severe pain in arm), PYREXIA (Fever 103F), LYMPHADENOPATHY (Swollen posterior cervical lymph node/ Enlargement of lymph nodes) and CHILLS (shaking chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and Unknown) for COVID-19 vaccination.     No Medical history was provided by the reporter.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced TREMOR (Shaking), PYREXIA (Fever 103F) and CHILLS (shaking chills). On an unknown date, the patient experienced PAIN IN EXTREMITY (severe pain in arm) and LYMPHADENOPATHY (Swollen posterior cervical lymph node/ Enlargement of lymph nodes). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 26-Apr-2021, TREMOR (Shaking), PYREXIA (Fever 103F) and CHILLS (shaking chills) had resolved. On 14-Jun-2021, LYMPHADENOPATHY (Swollen posterior cervical lymph node/ Enlargement of lymph nodes) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (severe pain in arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: 103 High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was unknown by the reporter.  Patient reported the blood work testing for Sjogren's disease and Lupus. Patient also reported that she had to put off a mammogram due to side effects as fever and shaking chills.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-100836 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: NNI On 06-Jun-2021: NNI On 07-Jun-2021: Patient initials was added On 10-Jun-2021: Event added On 14-Jun-2021: Event and Patient Initials updated.  E2b linked report added. On 27-Jul-2021: Significant FU :  AE Details provided
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Back pain, Chills, Fatigue, Myalgia
Clinical narrative: Arm is still sore to the touch; lost of smell; Back pain; Fatigue; Having chills in the body; Having fever; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), ANOSMIA (lost of smell), BACK PAIN (Back pain), FATIGUE (Fatigue) and CHILLS (Having chills in the body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), CHILLS (Having chills in the body) and PYREXIA (Having fever). On 25-Apr-2021, the patient experienced ANOSMIA (lost of smell), BACK PAIN (Back pain) and FATIGUE (Fatigue). On 30-Apr-2021, the patient experienced MYALGIA (Arm is still sore to the touch). The patient was treated with AZITHROMYCIN (oral) for Lung infection, at a dose of 500 mg once a day. On 22-Apr-2021, CHILLS (Having chills in the body) and PYREXIA (Having fever) outcome was unknown. On 25-Apr-2021, PAIN IN EXTREMITY (Arm pain) outcome was unknown. At the time of the report, ANOSMIA (lost of smell), BACK PAIN (Back pain), FATIGUE (Fatigue) and MYALGIA (Arm is still sore to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication was not provided by reporter. Additional information was provided that patient was waiting for test result. As per client.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Arm is still sore to the touch; lost of smell; Back pain; Fatigue; Having chills in the body; Having fever; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), ANOSMIA (lost of smell), BACK PAIN (Back pain), FATIGUE (Fatigue) and CHILLS (Having chills in the body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), CHILLS (Having chills in the body) and PYREXIA (Having fever). On 25-Apr-2021, the patient experienced ANOSMIA (lost of smell), BACK PAIN (Back pain) and FATIGUE (Fatigue). On 30-Apr-2021, the patient experienced MYALGIA (Arm is still sore to the touch). The patient was treated with AZITHROMYCIN (oral) for Lung infection, at a dose of 500 mg once a day. On 22-Apr-2021, CHILLS (Having chills in the body) and PYREXIA (Having fever) outcome was unknown. On 25-Apr-2021, PAIN IN EXTREMITY (Arm pain) outcome was unknown. At the time of the report, ANOSMIA (lost of smell), BACK PAIN (Back pain), FATIGUE (Fatigue) and MYALGIA (Arm is still sore to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication was not provided by reporter. Additional information was provided that patient was waiting for test result. As per client.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Rash
Clinical narrative: Dizziness; Rash all over the body; Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Dizziness), RASH (Rash all over the body ) and HEADACHE (Headache) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced DIZZINESS (Dizziness), RASH (Rash all over the body ) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), RASH (Rash all over the body ) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported. Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anaemia, Asthenia, Dehydration, Fatigue
Clinical narrative: Anemic; Urinary tract infection; Lethargic; Lost a lot of weight but has regained some of it back; Became weaker; Extreme fatigue; Dehydration; Lack of taste; This spontaneous case was reported by a consumer and describes the occurrence of ANAEMIA (Anemic), URINARY TRACT INFECTION (Urinary tract infection), LETHARGY (Lethargic), WEIGHT DECREASED (Lost a lot of weight but has regained some of it back) and ASTHENIA (Became weaker) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANAEMIA (Anemic), URINARY TRACT INFECTION (Urinary tract infection), LETHARGY (Lethargic), WEIGHT DECREASED (Lost a lot of weight but has regained some of it back), ASTHENIA (Became weaker), FATIGUE (Extreme fatigue), DEHYDRATION (Dehydration) and AGEUSIA (Lack of taste). At the time of the report, ANAEMIA (Anemic), URINARY TRACT INFECTION (Urinary tract infection), LETHARGY (Lethargic), WEIGHT DECREASED (Lost a lot of weight but has regained some of it back), ASTHENIA (Became weaker), FATIGUE (Extreme fatigue), DEHYDRATION (Dehydration) and AGEUSIA (Lack of taste) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-084862 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-084862:Crosslinked case for patient's mother
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Urinary tract infection, Weight decreased
Clinical narrative: Anemic; Urinary tract infection; Lethargic; Lost a lot of weight but has regained some of it back; Became weaker; Extreme fatigue; Dehydration; Lack of taste; This spontaneous case was reported by a consumer and describes the occurrence of ANAEMIA (Anemic), URINARY TRACT INFECTION (Urinary tract infection), LETHARGY (Lethargic), WEIGHT DECREASED (Lost a lot of weight but has regained some of it back) and ASTHENIA (Became weaker) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANAEMIA (Anemic), URINARY TRACT INFECTION (Urinary tract infection), LETHARGY (Lethargic), WEIGHT DECREASED (Lost a lot of weight but has regained some of it back), ASTHENIA (Became weaker), FATIGUE (Extreme fatigue), DEHYDRATION (Dehydration) and AGEUSIA (Lack of taste). At the time of the report, ANAEMIA (Anemic), URINARY TRACT INFECTION (Urinary tract infection), LETHARGY (Lethargic), WEIGHT DECREASED (Lost a lot of weight but has regained some of it back), ASTHENIA (Became weaker), FATIGUE (Extreme fatigue), DEHYDRATION (Dehydration) and AGEUSIA (Lack of taste) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-084862 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-084862:Crosslinked case for patient's mother
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: headache; fever of 100.2; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (fever of 100.2) and CHILLS (chills) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced HEADACHE (headache), PYREXIA (fever of 100.2) and CHILLS (chills). At the time of the report, HEADACHE (headache), PYREXIA (fever of 100.2) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no relevant concomitant medication provided no treatment information provided